219 related articles for article (PubMed ID: 33419780)
1. Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC).
Chen HX; Song M; Maecker HT; Gnjatic S; Patton D; Lee JJ; Adam SJ; Moravec R; Liu XS; Cerami E; Lindsay J; Tang M; Hodi FS; Wu CJ; Wistuba II; Al-Atrash G; Bernatchez C; Bendall SC; Hewitt SM; Sharon E; Streicher H; Enos RA; Bowman MD; Tatard-Leitman VM; Sanchez-Espiridion B; Ranasinghe S; Pichavant M; Del Valle DM; Yu J; Janssens S; Peterson-Klaus J; Rowe C; Bongers G; Jenq RR; Chang CC; Abrams JS; Mooney M; Doroshow JH; Harris LN; Thurin M
Clin Cancer Res; 2021 Sep; 27(18):5038-5048. PubMed ID: 33419780
[TBL] [Abstract][Full Text] [Related]
2. Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network.
Akturk G; Parra ER; Gjini E; Lako A; Lee JJ; Neuberg D; Zhang J; Yao S; Laface I; Rogic A; Chen PH; Sanchez-Espiridion B; Valle DMD; Moravec R; Kinders R; Hudgens C; Wu C; Wistuba II; Thurin M; Hewitt SM; Rodig S; Gnjatic S; Tetzlaff MT
Clin Cancer Res; 2021 Sep; 27(18):5072-5083. PubMed ID: 34253580
[TBL] [Abstract][Full Text] [Related]
3. Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC.
Sahaf B; Pichavant M; Lee BH; Duault C; Thrash EM; Davila M; Fernandez N; Millerchip K; Bentebibel SE; Haymaker C; Sigal N; Del Valle DM; Ranasinghe S; Fayle S; Sanchez-Espiridion B; Zhang J; Bernatchez C; Wu CJ; Wistuba II; Kim-Schulze S; Gnjatic S; Bendall SC; Song M; Thurin M; Lee JJ; Maecker HT; Rahman A
Clin Cancer Res; 2021 Sep; 27(18):5062-5071. PubMed ID: 34266889
[TBL] [Abstract][Full Text] [Related]
4. Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network.
Zeng Z; Fu J; Cibulskis C; Jhaveri A; Gumbs C; Das B; Sanchez-Espiridion B; Janssens S; Taing L; Wang J; Lindsay J; Vilimas T; Zhang J; Tokheim C; Sahu A; Jiang P; Yan C; Duose DY; Cerami E; Chen L; Cohen D; Chen Q; Enos R; Huang X; Lee JJ; Liu Y; Neuberg DS; Nguyen C; Patterson C; Sarkar S; Shukla S; Tang M; Tsuji J; Uduman M; Wang X; Weirather JL; Yu J; Yu J; Zhang J; Zhang J; Meerzaman D; Thurin M; Futreal A; Karlovich C; Gabriel SB; Wistuba II; Liu XS; Wu CJ
Clin Cancer Res; 2021 Sep; 27(18):5049-5061. PubMed ID: 33323402
[TBL] [Abstract][Full Text] [Related]
5. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
[TBL] [Abstract][Full Text] [Related]
6. Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.
Butterfield LH; Disis ML; Khleif SN; Balwit JM; Marincola FM
J Transl Med; 2010 Dec; 8():130. PubMed ID: 21138581
[TBL] [Abstract][Full Text] [Related]
7. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer.
Dyikanov D; Zaitsev A; Vasileva T; Wang I; Sokolov AA; Bolshakov ES; Frank A; Turova P; Golubeva O; Gantseva A; Kamysheva A; Shpudeiko P; Krauz I; Abdou M; Chasse M; Conroy T; Merriam NR; Alesse JE; English N; Shpak B; Shchetsova A; Tikhonov E; Filatov I; Radko A; Bolshakova A; Kachalova A; Lugovykh N; Bulahov A; Kilina A; Asanbekov S; Zheleznyak I; Skoptsov P; Alekseeva E; Johnson JM; Curry JM; Linnenbach AJ; South AP; Yang E; Morozov K; Terenteva A; Nigmatullina L; Fastovetz D; Bobe A; Balabanian L; Nomie K; Yong ST; Davitt CJH; Ryabykh A; Kudryashova O; Tazearslan C; Bagaev A; Fowler N; Luginbuhl AJ; Ataullakhanov RI; Goldberg MF
Cancer Cell; 2024 May; 42(5):759-779.e12. PubMed ID: 38744245
[TBL] [Abstract][Full Text] [Related]
9. Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer.
Annapragada A; Sikora A; Bollard C; Conejo-Garcia J; Cruz CR; Demehri S; Demetriou M; Demirdjian L; Fong L; Horowitz M; Hutson A; Kadash-Edmondson K; Kufe D; Lipkin S; Liu S; McCarthy C; Morgan M; Morris Z; Pan Y; Pasquini M; Schoenberger S; Van Allen E; Vilar E; Xing Y; Zha W; ; Odunsi A
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554617
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Systematic evaluation of immune regulation and modulation.
Stroncek DF; Butterfield LH; Cannarile MA; Dhodapkar MV; Greten TF; Grivel JC; Kaufman DR; Kong HH; Korangy F; Lee PP; Marincola F; Rutella S; Siebert JC; Trinchieri G; Seliger B
J Immunother Cancer; 2017; 5():21. PubMed ID: 28331613
[TBL] [Abstract][Full Text] [Related]
13. SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.
Hu-Lieskovan S; Bhaumik S; Dhodapkar K; Grivel JJB; Gupta S; Hanks BA; Janetzki S; Kleen TO; Koguchi Y; Lund AW; Maccalli C; Mahnke YD; Novosiadly RD; Selvan SR; Sims T; Zhao Y; Maecker HT
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33268350
[TBL] [Abstract][Full Text] [Related]
14. Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.
Tahara H; Sato M; Thurin M; Wang E; Butterfield LH; Disis ML; Fox BA; Lee PP; Khleif SN; Wigginton JM; Ambs S; Akutsu Y; Chaussabel D; Doki Y; Eremin O; Fridman WH; Hirohashi Y; Imai K; Jacobson J; Jinushi M; Kanamoto A; Kashani-Sabet M; Kato K; Kawakami Y; Kirkwood JM; Kleen TO; Lehmann PV; Liotta L; Lotze MT; Maio M; Malyguine A; Masucci G; Matsubara H; Mayrand-Chung S; Nakamura K; Nishikawa H; Palucka AK; Petricoin EF; Pos Z; Ribas A; Rivoltini L; Sato N; Shiku H; Slingluff CL; Streicher H; Stroncek DF; Takeuchi H; Toyota M; Wada H; Wu X; Wulfkuhle J; Yaguchi T; Zeskind B; Zhao Y; Zocca MB; Marincola FM
J Transl Med; 2009 Jun; 7():45. PubMed ID: 19534815
[TBL] [Abstract][Full Text] [Related]
15. Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.
Agrawal L; Engel KB; Greytak SR; Moore HM
Semin Cancer Biol; 2018 Oct; 52(Pt 2):26-38. PubMed ID: 29258857
[TBL] [Abstract][Full Text] [Related]
16. The Challenge for Development of Valuable Immuno-oncology Biomarkers.
Mehnert JM; Monjazeb AM; Beerthuijzen JMT; Collyar D; Rubinstein L; Harris LN
Clin Cancer Res; 2017 Sep; 23(17):4970-4979. PubMed ID: 28864725
[TBL] [Abstract][Full Text] [Related]
17. Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation.
Masucci GV; Cesano A; Hawtin R; Janetzki S; Zhang J; Kirsch I; Dobbin KK; Alvarez J; Robbins PB; Selvan SR; Streicher HZ; Butterfield LH; Thurin M
J Immunother Cancer; 2016; 4():76. PubMed ID: 27895917
[TBL] [Abstract][Full Text] [Related]
18. A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies.
Bot A; Ahn M; Bosch M; Brockstedt D; Butterfield LH; Cornforth A; Harrop R; Kast WM; Koya R; Marincola F; Margolin K; McCoy C; Pawelec G; Rothman J; Ramirez-Montagut T; Schlom J; Srivastava P; Wallis S; Walter S; Wang E; Waslif J
J Transl Med; 2012 Nov; 10():218. PubMed ID: 23127127
[TBL] [Abstract][Full Text] [Related]
19. Translating Immuno-oncology Biomarkers to Diagnostic Tests: A Regulatory Perspective.
Li Y; Veeraraghavan J; Philip R
Methods Mol Biol; 2020; 2055():701-716. PubMed ID: 31502175
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on the integration of Immuno-Oncology Biomarkers and drugs in a Health Care setting.
Vermaelen K; Waeytens A; Kholmanskikh O; Van den Bulcke M; Van Valckenborgh E
Semin Cancer Biol; 2018 Oct; 52(Pt 2):166-177. PubMed ID: 29170067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
